maralixibat chloride

maralixibat chloride (LIVMARLI) is an FDA-listed pharmaceutical active ingredient. Associated with Mirum Pharmaceuticals International B.V.. Route of administration: oral. Current US regulatory status: approved.

LIVMARLI is a marketed brand name for maralixibat chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

maralixibat chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.